Valbiotis SAS (ALVAL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.592x

Based on the latest financial reports, Valbiotis SAS (ALVAL) has a cash flow conversion efficiency ratio of -0.592x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.12 Million ≈ $-4.82 Million USD) by net assets (€6.96 Million ≈ $8.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Valbiotis SAS (ALVAL) net asset quality to measure how much of total assets are equity-financed.

Valbiotis SAS - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Valbiotis SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Valbiotis SAS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Valbiotis SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Valbiotis SAS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Patentus SA WAR:PAT	-0.050x
Spacenet Enterprises India Limited NSE:SPCENET	0.036x
Sin Heng Chan (Malaya) Bhd KLSE:4316	0.045x
BRIDGETEC Corp KQ:064480	-0.010x
Prefab Bucures RO:PREH	0.052x
Asia Poly Holdings Bhd KLSE:0105	0.030x
Muar Ban Lee Group Bhd KLSE:5152	0.017x
Alpine Summit Energy Partners Inc NASDAQ:ALPS	0.022x

Annual Cash Flow Conversion Efficiency for Valbiotis SAS (2015–2025)

The table below shows the annual cash flow conversion efficiency of Valbiotis SAS from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see ALVAL stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€6.96 Million ≈ $8.14 Million	€-8.04 Million ≈ $-9.40 Million	-1.155x	-3.77%
2024-12-31	€10.37 Million ≈ $12.12 Million	€-11.54 Million ≈ $-13.49 Million	-1.113x	-170.73%
2023-12-31	€19.60 Million ≈ $22.91 Million	€-8.06 Million ≈ $-9.42 Million	-0.411x	+40.47%
2022-12-31	€13.31 Million ≈ $15.56 Million	€-9.19 Million ≈ $-10.75 Million	-0.690x	-37.31%
2021-12-31	€14.23 Million ≈ $16.64 Million	€-7.16 Million ≈ $-8.37 Million	-0.503x	-232.07%
2020-12-31	€7.07 Million ≈ $8.27 Million	€2.69 Million ≈ $3.15 Million	0.381x	+163.19%
2019-12-31	€8.21 Million ≈ $9.60 Million	€-4.95 Million ≈ $-5.78 Million	-0.603x	+1.80%
2018-12-31	€7.41 Million ≈ $8.66 Million	€-4.55 Million ≈ $-5.31 Million	-0.614x	-186.99%
2017-12-31	€10.16 Million ≈ $11.88 Million	€-2.17 Million ≈ $-2.54 Million	-0.214x	+90.81%
2016-12-31	€369.00K ≈ $431.40K	€-858.00K ≈ $-1.00 Million	-2.325x	+73.80%
2015-12-31	€80.00K ≈ $93.53K	€-710.00K ≈ $-830.06K	-8.875x	--

About Valbiotis SAS

PA:ALVAL France Packaged Foods

Market Cap

$21.19 Million

€18.12 Million EUR

Market Cap Rank

#24909 Global

#406 in France

Share Price

€0.77

Change (1 day)

+1.46%

52-Week Range

€0.55 - €1.21

All Time High

€10.54